Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution

BACKGROUND: Interest in carbapenems has been rising in the last few years due to the emergence of drug resistant tuberculosis. Ertapenem (ETP), given once a day parenteral, and faropenem (FAR), oral, have a better administration profile than meropenem (MEM), imipenem (IPM) and doripenem (DOR). The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalo, Ximena, Satta, Giovanni, Ortiz Canseco, Julio, McHugh, Timothy D., Drobniewski, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457350/
https://www.ncbi.nlm.nih.gov/pubmed/32867678
http://dx.doi.org/10.1186/s12866-020-01954-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457350/
https://www.ncbi.nlm.nih.gov/pubmed/32867678
http://dx.doi.org/10.1186/s12866-020-01954-w

Ejemplares similares